2002 APR 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Bone marrow transplants using marrow from partially mismatched donors is often the best option for patients suffering from refractory acute leukemia, researchers say.
"Allogeneic transplantation is successful in a minority of patients with primary refractory acute leukemia (PRAL)," according to Dr. Seema Singhal and colleagues at Royal Marsden Hospital in Surrey, England, and the South Carolina Cancer Center in Columbia, South Carolina. "An HLA-matched sibling donor (MSD) is available only in 30-40% of the patients, whereas a partially mismatched related donor (PMRD) is available for …
No comments:
Post a Comment